Lilly: Taking the Fight to MDR-TB
Today's guest blog comes from Lilly's vice president of Global Health Programs, Evan Lee, M.D.
“Americans can no longer afford to be indifferent to the rise of drug-resistant tuberculosis.”
That’s the conclusion of an excellent op-ed in the International New York Times this week, penned by a journalist who recently visited Indonesia to investigate the impact of this disease. The country registers about 7,000 new cases of multidrug-resistant TB (MDR-TB) each year.